Mannkind Corporation Is A Biopharmaceutical Company Based In Danburyconnecticutdedicated To Developing And Commercializing Therapeutic Products For Chronic Diseaseswith A Strong Focus On Diabetes Managementthe Company Was Formed In 2001 Through The Merger Of Several Entities And Went Public In 2004Raising Significant Capital To Support Its Mission The Flagship Product Of Mannkind Is The Technosphere Insulin Systeman Inhaled Insulin Delivery Platform Designed For Rapid Acting Insulin Administration In Diabetes Patientsthe Company Has Invested In Clinical Trials To Advance This Non Invasive Drug Delivery Technologymannkind S History Reflects A Commitment To Innovation In Chronic Disease Treatmentdriven By The Vision Of Its Foundersalfred Mann And David Thomson
No conferences found for this company.
| Company Name | Mannkind Corporation |
| Country |
United States
|
| Address | 25134 Rye Canyon Loopsuite 300valencia Ca 91355 |
| Telephone | Login to View |
| Login to View |
